Safety and Effectiveness of NATRELLE® 410 Highly Cohesive, Anatomically Shaped, Silicone-filled X-Style and L-Style Breast Implants
Public ClinicalTrials.gov record NCT01785069. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospective Multicenter Study of the Safety and Effectiveness of NATRELLE® 410 Highly Cohesive Anatomically Shaped Silicone-filled X-style and L-style Breast Implants
Study identification
- NCT ID
- NCT01785069
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Allergan
- Industry
- Enrollment
- 355 participants
Conditions and interventions
Interventions
- Anatomically shaped, silicone-filled breast implants with low projection or extra-full projection Device
Device
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 9, 2012
- Primary completion
- Nov 29, 2015
- Completion
- Nov 29, 2015
- Last update posted
- Jun 24, 2020
2012 – 2015
United States locations
- U.S. sites
- 29
- U.S. states
- 17
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Laurence Berkowitz | Campbell | California | 95008 | — |
| Roy Hong | Palo Alto | California | 94301 | — |
| Eric Bachelor | Pleasanton | California | 94566 | — |
| Gregory Liebscher | Colorado Springs | Colorado | 80919 | — |
| Scott Spear | Washington D.C. | District of Columbia | 20007 | — |
| Calvin Peters | Orlando | Florida | 32801 | — |
| Walter Erhardt | Albany | Georgia | 31701 | — |
| James Namnoum | Atlanta | Georgia | 30342 | — |
| Janet Turkle | Carmel | Indiana | 46032 | — |
| Julene Samuels | Louisville | Kentucky | 40205 | — |
| Timothy Mickel | Monroe | Louisiana | 71201 | — |
| John Renucci | Grand Rapids | Michigan | 49503 | — |
| Steven Morris | Midland | Michigan | 48640 | — |
| Charles Nathan | Chesterfield | Missouri | 63005 | — |
| Herluf Jr. Lund | Chesterfield | Missouri | 63005 | — |
| Patricia McGuire | Creve Coeur | Missouri | 63141 | — |
| Perry Johnson | Omaha | Nebraska | 68118 | — |
| Peter Hyans | Berkeley Heights | New Jersey | 07922 | — |
| Peter Hetzler | Little Silver | New Jersey | 07739 | — |
| Caroline Glicksman | Sea Girt | New Jersey | 08750 | — |
| Tracy Pfeifer | Great Neck | New York | 10028 | — |
| Lloyd Gayle | New York | New York | 10021 | — |
| Raymond Isakov | Cleveland | Ohio | 44195 | — |
| Craig Colville | Toledo | Ohio | 43615 | — |
| Frank Barone | Toledo | Ohio | 43623 | — |
| Mary Gingrass | Nashville | Tennessee | 37203 | — |
| Patrick Maxwell | Nashville | Tennessee | 37212 | — |
| Jeffrey Friedman | Houston | Texas | 77030 | — |
| Thomas Blanchard | Newport News | Virginia | 23606 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01785069, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 24, 2020 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01785069 live on ClinicalTrials.gov.